MoonLake Immunotherapeutics
NASDAQ:MLTXBiotechnology
Healthcare
$11.25 +0.69%
+$0.13 today
- Market cap
- $957.45M
- Beta
- 1.04
- P/E (TTM)
- -5.4
- EPS (TTM)
- -$3.61
52W Low $5.95High $62.75
Volume 1.17M
Average 0.99M
Price history
MoonLake Immunotherapeutics SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-16.04%
Period high
$22.16
Period low
$9.55
Latest
$11.25
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Sep 30, 2026 | Sep 30, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| S-3ASR | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 | Aug 10, 2026 | Aug 10, 2026 | |
| 10-Q | Aug 10, 2026 | Aug 10, 2026 | |
| 8-K | Aug 10, 2026 | Aug 10, 2026 | |
| 4 | Jul 29, 2026 | Jul 29, 2026 | |
| 4 | Jul 23, 2026 | Jul 23, 2026 | |
| 4 | Jul 21, 2026 | Jul 21, 2026 | |
| 4 | Jul 20, 2026 | Jul 20, 2026 | |
| 8-K | Jul 15, 2026 | Jul 14, 2026 |
Competitors
Who does MoonLake Immunotherapeutics compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about MLTX's filings, answered from its disclosures.
What is the latest MLTX filing?
The latest filing shown is 8-K dated Nov 4, 2026.
How many recent filings does MLTX have?
Intrinsic Alpha currently shows 20 recent filings for MLTX.
Continue the stock analysis
Jump to another research area for this company.